GSA Capital Partners’s Milestone Pharmaceuticals MIST Stock Holding History
Bought
Maintained
Sold
Other funds holding MIST
KCM
GSA Capital Partners's MIST Position: Q3 2026 in Review
GSA Capital Partners opened a new position in Milestone Pharmaceuticals (MIST) in Q3 2026: 25,468 shares worth $22K. The stake represents ﹤0.01% of the portfolio and ranks #1809 among its holdings. This is a return to the name: GSA Capital Partners previously reported a position in MIST as recently as Q1 2026.
GSA Capital Partners first reported a position in MIST in Q1 2023 and has held it in 7 quarters since. The position peaked at $477K in Q4 2025. 74 funds tracked by Wall St. Rank hold MIST as of Q3 2026.
- GSA Capital Partners held 25,468 shares of Milestone Pharmaceuticals worth $22K as of Q3 2026.
- Milestone Pharmaceuticals was a new GSA Capital Partners position in Q3 2026.
- Milestone Pharmaceuticals made up ﹤0.01% of GSA Capital Partners's portfolio in Q3 2026, its #1809 holding.
- GSA Capital Partners first reported a position in Milestone Pharmaceuticals in Q1 2023 and has held it in 7 quarters since.
- GSA Capital Partners's Milestone Pharmaceuticals position peaked at $477K in Q4 2025.
- 74 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.